Antimicrobial activities of silver dressings:: an in vitro comparison

被引:396
作者
Ip, M [1 ]
Lui, SL
Poon, VKM
Lung, I
Burd, A
机构
[1] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Microbiol, Shatin, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Surg, Shatin, Hong Kong, Peoples R China
关键词
D O I
10.1099/jmm.0.46124-0
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A range of silver-coated or -impregnated dressings are now commercially available for use but comparative data on their antimicrobial efficacies are limited. The antibacterial activities of five commercially available silver-coated/impregnated dressings were compared against nine common burn-wound pathogens, namely methicillin-sensitive and -resistant Staphylococcus aureus (MRSA), Enterococcus faecalis, Pseudomonas aeruginosa, Escherichia coli, Enterobacter cloacae, Proteus vulgaris, Acinetobacter baumannii and a multi-drug-efflux-positive Acinetobacter baumannii (BM4454), using a broth culture method. The rapidity and extent of killing of these pathogens under in vitro conditions were evaluated. All five silver-impregnated dressings investigated exerted bactericidal activity, particularly against Gram-negative bacteria, including Enterobacter species, Proteus species and E coli. The spectrum and rapidity of action, however, ranged widely for different dressings. Acticoat and Contreet had a broad spectrum of bactericidal activities against both Gram-positive and -negative bacteria. Contreet was characterized by a very rapid bactericidal action and achieved a reduction of >= 10 000 c.f.u. ml(-1) in the first 30 min for Enterobacter cloacae, Proteus vulgaris, Pseudomonas aeruginosa and Acinetobacter baumanii. Other dressings demonstrated a narrower range of bactericidal activities. Understanding the characteristics of these dressings may enable them to be targeted more appropriately according to the specific requirements for use of a particular dressing, as in for prophylaxis in skin grafting or for an infected wound with MRSA.
引用
收藏
页码:59 / 63
页数:5
相关论文
共 22 条
[1]   Aquacel Ag® in the management of partial-thickness burns:: Results of a clinical trial [J].
Caruso, DM ;
Foster, KN ;
Hermans, MHE ;
Rick, C .
JOURNAL OF BURN CARE & REHABILITATION, 2004, 25 (01) :89-97
[2]   Anti-infective efficacy of silver-coated medical prostheses [J].
Darouiche, RO .
CLINICAL INFECTIOUS DISEASES, 1999, 29 (06) :1371-1377
[3]  
FOX CL, 1968, ARCH SURG-CHICAGO, V96, P184
[4]   An in vitro study of the anti-microbial efficacy of a 1% silver sulphadiazine and 0.2% chlorhexidine digluconate cream Silvazine™, 1% silver sulphadiazine cream Flamazine™ and a silver coated dressing Acticoat™ [J].
Fraser, JF ;
Bodman, J ;
Sturgess, R ;
Faoagali, J ;
Kimble, RM .
BURNS, 2004, 30 (01) :35-41
[5]   Silver nanoparticles and polymeric medical devices: a new approach to prevention of infection? [J].
Furno, F ;
Morley, KS ;
Wong, B ;
Sharp, BL ;
Arnold, PL ;
Howdle, SM ;
Bayston, R ;
Brown, PD ;
Winship, PD ;
Reid, HJ .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 54 (06) :1019-1024
[6]  
Gupta A, 1998, APPL ENVIRON MICROB, V64, P5042
[7]   Therapeutic efficacy of three silver dressings in an infected animal model [J].
Heggers, J ;
Goodheart, RE ;
Washington, J ;
McCoy, L ;
Carino, E ;
Dang, T ;
Edgar, P ;
Maness, C ;
Chinkes, D .
JOURNAL OF BURN CARE & REHABILITATION, 2005, 26 (01) :53-56
[8]   Wound dressings in diabetic foot disease [J].
Hilton, JR ;
Williams, DT ;
Beuker, B ;
Miller, DR ;
Harding, KG .
CLINICAL INFECTIOUS DISEASES, 2004, 39 :S100-S103
[9]   Controlling wound bioburden with a novel silver-containing Hydrofiber® dressing [J].
Jones, SA ;
Bowler, PG ;
Walker, M ;
Parsons, D .
WOUND REPAIR AND REGENERATION, 2004, 12 (03) :288-294
[10]  
Karlsmark T, 2003, J Wound Care, V12, P351